152 related articles for article (PubMed ID: 11562343)
1. There is synergism between high-intensity, low-frequency ultrasound and streptokinase but not with eptifibatide, heparin, and aspirin. Differential effects on fresh and aged blood clots. An in vitro study.
Wyshelesky A; Iakobishvili Z; Matz I; Golovchiner G; Vaturi M; Siegel RJ; Birnbaum Y
Thromb Res; 2001 Aug; 103(4):337-44. PubMed ID: 11562343
[TBL] [Abstract][Full Text] [Related]
2. Ultrasound has synergistic effects in vitro with tirofiban and heparin for thrombus dissolution.
Birnbaum Y; Atar S; Luo H; Nagai T; Siegel RJ
Thromb Res; 1999 Dec; 96(6):451-8. PubMed ID: 10632468
[TBL] [Abstract][Full Text] [Related]
3. Synergism of aspirin and heparin with a low-frequency non-invasive ultrasound system for augmentation of in-vitro clot lysis.
Atar S; Neuman Y; Miyamoto T; Chen M; Birnbaum Y; Luo H; Kobal S; Siegel RJ
J Thromb Thrombolysis; 2003 Jun; 15(3):165-9. PubMed ID: 14739625
[TBL] [Abstract][Full Text] [Related]
4. In vitro ultrasound augmented clot dissolution--what is the optimal timing of ultrasound application?
Shlamovitz GZ; Iakobishvili Z; Matz I; Golovchiner G; Lev E; Siegel RJ; Birnbaum Y
Cardiovasc Drugs Ther; 2002 Dec; 16(6):521-6. PubMed ID: 12766386
[TBL] [Abstract][Full Text] [Related]
5. The effects of streptokinase and hydroxyethyl starch on in vitro clot disruption by ultrasound.
Adler Y; Attar D; Vaturi M; Golovchiner G; Iakobishvili Z; Battler A; Siegel RJ; Birnbaum Y
Cardiovasc Drugs Ther; 2001 Mar; 15(2):119-23. PubMed ID: 11669404
[TBL] [Abstract][Full Text] [Related]
6. Changes in clot lysis levels of reteplase and streptokinase following continuous wave ultrasound exposure, at ultrasound intensities following attenuation from the skull bone.
Härdig BM; Carlson J; Roijer A
BMC Cardiovasc Disord; 2008 Aug; 8():19. PubMed ID: 18727834
[TBL] [Abstract][Full Text] [Related]
7. Comparative immunogenicity and thrombolytic properties toward arterial and venous thrombi of streptokinase and recombinant staphylokinase in baboons.
Collen D; De Cock F; Stassen JM
Circulation; 1993 Mar; 87(3):996-1006. PubMed ID: 8443918
[TBL] [Abstract][Full Text] [Related]
8. Effect of low frequency ultrasound on combined rt-PA and eptifibatide thrombolysis in human clots.
Meunier JM; Holland CK; Pancioli AM; Lindsell CJ; Shaw GJ
Thromb Res; 2009; 123(3):528-36. PubMed ID: 18619651
[TBL] [Abstract][Full Text] [Related]
9. Augmentation of in-vitro clot dissolution by low frequency high-intensity ultrasound combined with antiplatelet and antithrombotic drugs.
Atar S; Luo H; Birnbaum Y; Nagai T; Siegel RJ
J Thromb Thrombolysis; 2001 May; 11(3):223-8. PubMed ID: 11577261
[TBL] [Abstract][Full Text] [Related]
10. A bleeding model in rabbits demonstrate fresh clot selectivity for a genetically engineered variant of tissue-type plasminogen activator and for streptokinase.
Wikström K; Mattsson C; Pohl G
Thromb Res; 1993 May; 70(3):217-24. PubMed ID: 8392227
[TBL] [Abstract][Full Text] [Related]
11. Low-energy ultrasound exposure of the streptokinase molecule may enhance but also attenuate its fibrinolytic properties.
Härdig BM; Persson HW; Olsson SB
Thromb Res; 2006; 117(6):713-20. PubMed ID: 15993473
[TBL] [Abstract][Full Text] [Related]
12. Pro- and antifibrinolytic effects of ultrasound on streptokinase-induced thrombolysis.
Nilsson AM; Odselius R; Roijer A; Olsson SB
Ultrasound Med Biol; 1995; 21(6):833-40. PubMed ID: 8571471
[TBL] [Abstract][Full Text] [Related]
13. Blood clot disruption in vitro using shockwaves delivered by an extracorporeal generator after pre-exposure to lytic agent.
Goldenstedt C; Birer A; Cathignol D; Lafon C
Ultrasound Med Biol; 2009 Jun; 35(6):985-90. PubMed ID: 19285784
[TBL] [Abstract][Full Text] [Related]
14. In vitro effect of the potent poly(ADP-ribose) polymerase (PARP) inhibitor INO-1001 alone and in combination with aspirin, eptifibatide, tirofiban, enoxaparin or alteplase on haemostatic parameters.
Tóth O; Szabó C; Kecskés M; Pótó L; Nagy A; Losonczy H
Life Sci; 2006 Jun; 79(4):317-23. PubMed ID: 16480745
[TBL] [Abstract][Full Text] [Related]
15. [On thrombolysis with various fibrinolytic agents. II. In vitro studies on intravitally-formed human blood clots].
Schmidt HW
Klin Wochenschr; 1966 Jun; 44(11):621-5. PubMed ID: 5987967
[No Abstract] [Full Text] [Related]
16. Effects of organic extracts and their different fractions of five Bangladeshi plants on in vitro thrombolysis.
Emran TB; Rahman MA; Uddin MM; Rahman MM; Uddin MZ; Dash R; Layzu C
BMC Complement Altern Med; 2015 Apr; 15():128. PubMed ID: 25902818
[TBL] [Abstract][Full Text] [Related]
17. Ultrasonic clot disruption: an in vitro study.
Hong AS; Chae JS; Dubin SB; Lee S; Fishbein MC; Siegel RJ
Am Heart J; 1990 Aug; 120(2):418-22. PubMed ID: 2382618
[TBL] [Abstract][Full Text] [Related]
18. Augmentation of in-stent clot dissolution by low frequency ultrasound combined with aspirin and heparin. An ex-vivo canine shunt study.
Neuman Y; Rukshin V; Tsang V; Atar S; Miyamoto T; Luo H; Kobal S; Thompson T; Birnbaum Y; Horzewski M; Siegel RJ; Kaul S
Thromb Res; 2003; 112(1-2):99-104. PubMed ID: 15013280
[TBL] [Abstract][Full Text] [Related]
19. Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis.
Marsh JN; Senpan A; Hu G; Scott MJ; Gaffney PJ; Wickline SA; Lanza GM
Nanomedicine (Lond); 2007 Aug; 2(4):533-43. PubMed ID: 17716136
[TBL] [Abstract][Full Text] [Related]
20. Rapid dissociation of platelet-rich fibrin clots in vitro by a combination of plasminogen activators and antiplatelet agents.
Lam SC; Dieter JP; Strebel LC; Taylor TM; Muscolino G; Feinberg H; Le Breton GC
J Pharmacol Exp Ther; 1991 Dec; 259(3):1371-8. PubMed ID: 1762085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
